The Late Effects of Thorotrast Administration. A Review and an Experimental Study.
1955

The Late Effects of Thorotrast Administration

Sample size: 80 publication Evidence: moderate

Author Information

Author(s): J. P. Guimaraes, L. F. Lamerton, W. R. Christensen

Primary Institution: Royal Marsden Hospital

Hypothesis

Does intravenously administered thorotrast have carcinogenic effects?

Conclusion

The study found evidence of degenerative changes and tumors in mice after thorotrast administration, suggesting a potential causal relationship.

Supporting Evidence

  • Five hepatomas were found in the liver of thorotrast-injected mice.
  • One reticulo-endothelioma was observed in the liver.
  • Seven lung tumors were identified in mice examined more than 15 months after injection.
  • Control animals that lived over 12 months showed no tumors.

Takeaway

This study looked at how a substance called thorotrast might cause cancer in mice, and they found some signs that it could be harmful.

Methodology

The study involved injecting thorotrast into groups of mice and observing the effects over time, including histological examinations.

Limitations

The number of animals involved was small, and some records of deaths were incomplete.

Participant Demographics

Male Schofield albino mice, approximately 8 weeks old at the start of the experiment.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication